Entrada Therapeutics, Inc. (TRDA)
10.80
-0.27
(-2.44%)
USD |
NASDAQ |
Feb 12, 16:00
10.77
-0.03
(-0.28%)
After-Hours: 20:00
Entrada Therapeutics EPS Diluted (Quarterly) : -1.064 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Kodiak Sciences, Inc. | -1.163 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.1601 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -44.13M |
| Revenue (Quarterly) | 1.614M |
| Total Expenses (Quarterly) | 45.75M |
| Enterprise Value | 138.33M |
| Gross Profit Margin (Quarterly) | 25.65% |
| Profit Margin (Quarterly) | -2.73K% |
| Earnings Yield | -23.18% |
| Normalized Earnings Yield | -22.88 |